Seòmar agus comataidhean

Integration Authorities have delegated responsibility in Scotland for providing local alcohol and drug services. This activity is coordinated by Alcohol and Drug Partnerships (ADPs) and funded by the Scottish Government. In line with the Verity House Agreement, the Integration Authorities and ADPs have a significant amount of autonomy over local decision making.

From 2022 Local services have been directed to implement the Medication Assisted Treatment standards. MAT Standard 1 has an aim to ensure individuals get into treatment and have access to workers on the same day they ask for it.

The Scottish Government also provide additional funding to Alcohol and Drug Partnerships to ensure this is achievable.

We continue to monitor the impact and effectiveness of the Young Patients Family Fund (YPFF) and keep this under review.

Work on developing a Stigma Action Plan has taken place, alongside progress with the National Collaborative, who are publishing a Charter of Rights for People Affected by Substance Use on 11 December 2024.

The Charter was developed by a wide network of people with experience of substance use and aims to shift power and change culture, by empowering people affected by substance use to name and claim their rights, and be involved in decisions which impact them. It will also support service providers to understand how to realise these rights.

The purpose of the Medication Assisted Treatment standards is to improve access to treatment and enable people to make an informed choice about their care. The work that services are doing to embed the MAT standards is part of realising the right to health, and therefore very much aligns with the Charter of Rights.

Since the launch of the Young Patients Family Fund in July 2021, Health Boards have reported the following number of claims were made.

The Scottish Government continues to support local areas provide medication assisted treatment.

The Scottish Government also has overall Drug waiting times in terms of accessing services, for which a target was set that 90% of people accessed treatment within 3 weeks.

Since the introduction of the Medication Assisted Treatment Standards in 2021, as reported in the National Benchmarking Report published in July 2024, the waiting times have dropped and show that 75% of people now wait one day or less to access a form of treatment.

Latest full year data on the Young Patients Family Fund (YPFF) is available for financial year 2023-24. In 2023-24 NHS Greater Glasgow and Clyde reported that 4007 claims were made.

The Scottish Government agreed with the recommendations of the Drug Deaths Taskforce in that more choice should be available on the types of Opioid Substitution Therapy (OST) offered to individuals where appropriate.

Pilots of a non-statutory support scheme began in spring 2023, with funding provided for distribution by local services to remove the barrier of transport costs for people with substance dependency, when accessing treatment. These Pathfinders, also covering people with multiple and complex needs, are taking place in 11 locations, with full implementation to support a national practice model expected to be complete in Summer 2025.

As part of their work to support implementation of the MAT standards, the 2023 National Benchmarking Report published by Public Health Scotland (PHS), detailed assessments of how areas are trying to overcome the challenges of rurality. Approaches include: high use of self-referral and telephone, ‘tele-health’ technology such as NEAR ME; wide use of bus passes, taxis, and third sector to take people to appointments. Also offering a choice of venues to be seen at, such as a GP practice, home and community hubs, as well as settings to deliver care when weather disrupts usual access.

A strength in many areas is the utilisation of informal local networks and relationships to respond to urgent presentations, even when no formal arrangements are in place. Many areas now also have formal arrangements with other Health Boards to utilise and share expertise.

The Drug Deaths Taskforce was set up in 2019 to provide evidence-based expert advice on tackling the misuse of drugs. Toxicology results tell us that opiates/opioids were, and still are the main substances implicated in drug deaths in Scotland, with polydrug use being a significant factor.

After January 2021 when the National Mission was launched, the Scottish Government published the MAT standards, and through their continuing implementation, transformational change has taken place in drug treatment services throughout Scotland.

Methadone remains the primary form of medication assisted treatment, as an internationally accepted and evidence-based form of opioid antagonist. In the 12-month period ending 31 March 2024, Opioid Substitution Therapy was prescribed to a minimum of 29,817 people for the treatment of opioid dependence.